Harvard Business Review

NOVEMBER 8, 2017

The health care system in the United States, with its technological prowess and massive infrastructure, often serves as a reference point for rapidly developing economies around the world while they build their own medical systems. Over the same period, pharmaceutical exports have doubled. Insight Center. Transforming Health Care.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

FEBRUARY 2, 2015

Science and engineering professionals work closely with experienced technicians to produce next-generation batteries, not forged metal. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support. But just as U.S.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

JUNE 21, 2013

Given the forecasts of uncertain global economic growth, we might expect companies to hold off from hiring new employees and to limit whatever international hiring they do to emerging markets. We also find that companies in developed areas plan to hire in other developed regions (e.g., Asia into North America).

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

JANUARY 5, 2018

But over and over again in our three decades of experience as talent development and retention specialists, we’ve seen that companies consistently overlook half of them. These are jobs in R&D, technology, and other areas vital to a firm’s strategic direction, product development, and process efficiency.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. They will not, it must be noted, alter how the role of manufacturing evolves as economies develop.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

OCTOBER 29, 2012

Consider the recent phenomena of shoestring 3D design labs or the biofabrication labs at MIT , which are taking the plunge into synthetic biology with far fewer resources than the genetic engineers at government labs. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

MARCH 16, 2015

.” CEOs also worried about whether their high potential employees were being properly developed. food processor General Mills, noting that his company was quickly expanding internationally, said, “One of our challenges was how to develop a truly globally mobile culture. Ken Powell of U.S. Operating in a Global Marketplace.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

SEPTEMBER 15, 2014

When networks develop into communities, the results can be powerful. Look at the accomplishments of Wikipedia contributors, open-source software developers who find and fix bugs in Linux, or doctors who help each another with difficult diagnoses as part of the Sermo social network.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets. Facilitate discussion between competitors.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

FEBRUARY 14, 2014

I’ve been watching the global economy for decades, and it seems to me that growth in the United States is about to speed up, while growth in the emerging markets is slowing down. an engine manufacturer, began building an engine for long-haul trucks optimized to run on natural gas. As it develops, the U.S. Not for a while.

Chemicals 8

Chemicals Pharmaceuticals Energy Creativity 8

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Develop Creative Discontent. Frugal innovations require frugal thinking — an ability to engineer cost?conscious

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. The Valley of Death. Innovating the Innovation Process. Killing Ideas Faster.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

JULY 7, 2011

Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser. He reached out for coaching when one of his reporting senior marketing staff members was grabbing credit for other people's work and undermining his department's efforts.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

JUNE 3, 2013

Many wonder why an academy company like P&G, historically known for developing talent, did not, or was not able to, promote a successor from within its ranks. Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? Where was its leadership bench?

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. At Nokia, the senior leadership team was for a long time extraordinarily homogenous (mostly men, mostly from Finland, mostly software engineers, mostly educated in Helsinki). It’s a tough challenge.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

DECEMBER 29, 2015

For these reasons, we need to look beyond the current horizon of those who already have diabetes and get a firmer grip on the even greater proportion of the population — nearly 2 billion people — who are at risk of developing the condition. With our knowledge and position in the market, how can we not do something to help?

Health Care 8

Health Care NGO Pharmaceuticals Globalization 8

Harvard Business Review

APRIL 15, 2015

million industrial robots are in use or available in various industries including automotive, electronics, rubber and plastics, cosmetics, pharmaceutical, and food and beverage. Their market value is $9.5 Today, more than 1.3 A more complete history can be found here.).

Definition 8

Definition Ethics Industry Automotive 8

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. Some regenerative medicines stimulate our bodies to regrow or repair, so the field can include the use of stem cells for tissue engineering. Gene therapy is also a part of this trend. Agilis Biotherapeutics, a U.S.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. HR has the job of developing the human capabilities needed to capture the IoT opportunity.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

NOVEMBER 20, 2015

He is poised to become the leader in this segment of a multi-billion dollar market. Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

NOVEMBER 12, 2018

With dozens of other genetically engineered therapies moving through clinical trials, the long-promised era of personalized, gene-based medicine seemed to be at hand. ” As this first wave of genetic treatments hits the market, industry leaders face a stark choice. Creating better outcomes at reduced cost.

Business Model 10

Business Model Insurance Cost Bond 10

Harvard Business Review

JUNE 23, 2015

When I was in the midst of researching what caused cross-functional teams to succeed — and finding that many of them failed — I discovered a deeply dysfunctional development project in a huge multinational IT company. The company had invested $100 million in the project, which involved three divisions. You and Your Team.

Team 8

Team Project Software Engineering 8

Harvard Business Review

SEPTEMBER 5, 2016

Each branch makes its own loan decisions, sets its own pricing on loans and deposits, controls its own marketing budget, runs its own website (on a shared platform), and serves all customer segments — from individuals to multinationals — within its catchment area. The case of Svenska Handelsbanken is illustrative.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

OCTOBER 11, 2013

Much as I want to believe that a glaringly good idea will stand on its merits, I have come to realize that just like any product or service, ideas require good marketing if they’re going to reach their intended customers. New ideas tend to evoke fear and anger – we are programmed to prefer the comfort and safety of established norms.

Innovation 11

Innovation Christensen Decisionmaking CTO 11

Harvard Business Review

JULY 12, 2011

Boston Scientific a few years back launched a secret project to reverse-engineer the technology of its single-source supplier of coronary stents. The long-standing exclusive arrangement between Xerox and Fuji Photo Film in Japan is one example; pharmaceutical licensing across markets is another. It can work, but it's rare.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

NOVEMBER 7, 2012

3M and Google, among others, have given "innovation time off" to their scientists and engineers. Over the last few years, its big new product lines — including a healthy Veg Pot and its This Water line — have both come from ideas conceived and developed by mid-level employees. Tolerance of Failure.

Company 8

Company Stage-Gate Innovation Bureaucracy 8

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. To illustrate this, consider that patent applications in the U.S.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

JUNE 30, 2014

In the words of Empson and Alvehus they have gained “legitimacy to lead through market success.” So there is something about needing to keep all 500 partners happy which brings a level of politics, which you wouldn’t get if we were an engineering company or a pharmaceuticals company.”.

Politics 8

Politics Pharmaceuticals Consultative Consensus 8